# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Asensus Surgical (AMEX:ASXC) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0....
KARL STORZ Endoscopy-America has agreed to acquire Asensus Surgical for $0.35 per share, representing a 67% premium. This acqui...